News

Public · Published

China Life Insurance's New Business Value Growth Remains Bright Spot — Market Talk

China Life Insurance's new business value grew around 13% year on year in the nine months ended September, despite industry decline and net profit missing estimates. DBS cut its 2026–2027 earnings projections by 20%–34% and lowered its target price to HK$36.50 from HK$38.00, while retaining a buy rating.

Published:

Updated:

What happened

China Life Insurance’s new business value grew around 13% year on year in the nine months ended September, despite industry decline and net profit missing estimates. DBS cut its 2026–2027 earnings projections by 20%–34% and lowered its target price to HK$36.50 from HK$38.00, while retaining a buy rating.

Confirmed

Global impact / market context

The contrast suggests stronger new-business growth is not yet translating into earnings that meet expectations. Lower profit forecasts can weigh on expected returns, while continued growth in new policies could support future revenue; the article identifies bancassurance, selling insurance through banks, as a potential longer-term growth channel.

Analyst inference

DBS describes new business value growth as a bright spot against industry decline, but its lower earnings projections and target price reflect concern about near-term profit. China Life shares nevertheless closed 3.85% higher at HK$24.80, showing the reported session’s direction, not its cause.

Analyst inference

What to watch

  1. China Life’s next reported new business value growth would show whether the roughly 13% increase continues despite the industry decline described by DBS. Analyst inference
  2. Future earnings results will indicate whether profits recover enough to meet updated expectations after DBS cut its 2026–2027 projections by 20%–34%. Analyst inference
  3. The company says it is confident in its 2027 growth outlook and cites bancassurance’s potential; future disclosures could clarify whether that channel delivers growth. Confirmed

Evidence

  • Original source link unavailable